Yasushi Suwazono Selected Research

Isolated Systolic Hypertension

1/2009	Smoking as an independent risk factor for hypertension: a 14-year longitudinal study in male Japanese workers.
1/2006	The -1438A/G polymorphism in the 5-hydroxytryptamine receptor 2A gene is related to hyperuricemia, increased gamma-glutamyl transpeptidase and decreased high-density lipoprotein cholesterol level in the Japanese population: a prospective cohort study over 5 years.
12/2005	A longitudinal study on the relationship between shift work and the progression of hypertension in male Japanese workers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Suwazono Research Topics

Disease

10	Hypertension (High Blood Pressure) 11/2021 - 03/2004
9	Cadmium Poisoning (Itai Itai) 01/2023 - 08/2004
4	Neoplasms (Cancer) 12/2023 - 04/2018
4	Hyperuricemia 11/2016 - 01/2006
4	Obesity 05/2016 - 01/2006
4	Hypercholesterolemia 10/2014 - 01/2006
4	Overweight 05/2014 - 01/2004
3	Renal Insufficiency (Renal Failure) 10/2020 - 01/2018
3	Proteinuria 04/2018 - 03/2002
3	Isolated Systolic Hypertension 01/2009 - 12/2005
2	Insulin Resistance 01/2017 - 10/2014
2	Stroke (Strokes) 07/2013 - 01/2006
2	Osteoporosis 03/2011 - 08/2010
2	Diabetes Mellitus 05/2006 - 06/2005
1	Glucose Intolerance 05/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 04/2018
1	Lung Neoplasms (Lung Cancer) 04/2018
1	Uterine Neoplasms (Uterine Cancer) 04/2018
1	Urologic Diseases (Urinary Tract Disease) 01/2018
1	Poisoning 07/2017
1	Iron Overload 01/2017
1	Bone Diseases (Bone Disease) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 05/2016
1	Inflammation (Inflammations) 12/2014
1	Wrist Fractures 03/2011
1	Osteoporotic Fractures 03/2011
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2011
1	Metabolic Bone Diseases (Osteopenia) 08/2010
1	Glycosuria 03/2002

Drug/Important Bio-Agent (IBA)

18	CadmiumIBA 12/2023 - 01/2003
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 06/2005
7	Uric Acid (Urate)IBA 11/2016 - 03/2004
6	CreatinineIBA 01/2020 - 12/2005
5	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2011 - 03/2004
5	Antihypertensive Agents (Antihypertensives)IBA 01/2009 - 03/2004
4	CholesterolIBA 05/2011 - 01/2006
4	G-protein beta3 subunitIBA 06/2006 - 01/2004
2	Hexosaminidases (Hexosaminidase)IBA 12/2023 - 01/2022
2	Ethanol (Ethyl Alcohol)IBA 11/2021 - 11/2016
2	GTP-Binding Proteins (G-Protein)IBA 05/2014 - 01/2006
2	Transaminases (Aminotransferases)IBA 05/2011 - 02/2008
2	Guanosine Triphosphate (GTP)IBA 02/2008 - 03/2004
2	Low Density Lipoprotein Receptor-Related Protein-5IBA 06/2006 - 01/2006
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	antineoplaston A10 (A 10)IBA 10/2020
1	Ferritins (Ferritin)IBA 01/2017
1	CarbohydratesIBA 05/2016
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 05/2016
1	C-Reactive ProteinIBA 12/2014
1	Insulin (Novolin)FDA Link 10/2014
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2014
1	Biological FactorsIBA 07/2013
1	ORALIT (ORS)IBA 03/2011
1	Vascular Endothelial Growth Factor DIBA 01/2011
1	Gout Suppressants (Antigout Agents)IBA 06/2006
1	Serotonin ReceptorsIBA 01/2006
1	LipidsIBA 01/2006
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2006
1	HDL CholesterolIBA 01/2006
1	Indicators and Reagents (Reagents)IBA 12/2004
1	Glucose (Dextrose)FDA LinkGeneric 03/2002
1	Proteins (Proteins, Gene)FDA Link 03/2002

Therapy/Procedure

1	General Anesthesia 01/2021
1	Anesthesia 01/2021
1	Bathroom Equipment 01/2018